# Diabetes (Hyperglycemia/Mild DKA/Mild HHS) - Acute Care Pathway

## Objective
Enable physiologic monitoring and geographically-distributed care coordination to ensure effective care for patients with uncontrolled hyperglycemia refractory to outpatient management requiring IV insulin, oral titration, and IV hydration.

## Duration
**2-5 days** (typical 3-4 days)

---

## Eligibility Criteria

### Inclusion
- **Uncontrolled hyperglycemia** refractory to outpatient management requiring:
  - IV insulin infusion (low-dose protocol), OR
  - Oral medication titration/optimization, OR
  - IV hydration for dehydration/hyperglycemia

### Exclusion Criteria
- **Moderate to severe DKA/HHS** (requires ICU)
- **Insulin drip** (continuous high-rate infusion)
- **Altered mental status** (GCS <15)

---

## Primary Outcome Measures

| Outcome | Timeframe | Target |
|---------|-----------|--------|
| **30-Day ED Presentation** | 30 days | Minimize hyperglycemia-related ED visits |
| **30-Day Readmission** | 30 days | <15% |
| **30-Day Mortality** | 30 days | <3% |
| **Patient Satisfaction** | End of program | >85% satisfaction |

---

## Devices & Monitoring Equipment

See **[Devices Reference](../../shared/devices.md)** for complete specifications.

### Required Devices
- **Connected Glucometer** (ForaCare Test N Go)
  - **Critical**: Q6hrs glucose monitoring minimum during acute phase
  - Includes test strips, lancets, control solution
- **Connected BP Cuff** (Welch Allyn 1700 OR Omron BP7000)
  - Monitor for hypotension (dehydration) or hypertension (comorbidity)

### Optional Devices (based on severity and clinician preference)
- **Continuous Telemetry** (VitalConnect VitalPatch)*
  - For patients with cardiac risk or DKA concerns
- **Connected Pulse Oximeter** (Nonin 3230)*

---

## Daily Monitoring Protocol

### Clinical Team Reviews (Daily)
1. **Physiologic Data Review**
   - **Glucose trends**: Q6hrs readings (fasting, pre-meal, post-meal, bedtime)
   - **Glucose variability**: Wide swings indicate poor control or insulin dosing issues
   - **BP**: Monitor hydration status
   - **Heart rate**: Tachycardia may indicate dehydration or DKA

2. **Subjective Patient Data Review**
   - **Daily Diabetes Symptom Checker**: See **[Diabetes Questionnaire](../../shared/questionnaires/diabetes-questionnaire.md)**
     - Hypoglycemia symptoms (sweating, shaking, confusion)
     - Hyperglycemia symptoms (thirst, polyuria, blurred vision, fatigue)
     - Nausea/vomiting (DKA warning)
     - Contributing factors (illness, stress, dietary, activity)
     - Medication adherence

3. **Patient Task Compliance**
   - Q6hrs glucose monitoring
   - Food diary (carbohydrate tracking)
   - Insulin/medication administration
   - Hydration (fluid intake tracking)

---

## Alert Thresholds & Escalations

See **[Universal Alert Thresholds](../../shared/alert-thresholds.md)** for complete table.

### Diabetes-Specific Critical Alerts

| Parameter | Threshold | Clinical Significance | Action |
|-----------|-----------|----------------------|--------|
| **Glucose** | ≤2.8 mmol/L (50 mg/dL) | **Severe hypoglycemia** | **IMMEDIATE**: 15-15 rule, hold insulin, assess cause |
| **Glucose** | ≥16.7 mmol/L (300 mg/dL) | Severe hyperglycemia, possible DKA/HHS | **Urgent**: Check ketones, assess for DKA, insulin adjustment |
| **Glucose** | ≥20 mmol/L + nausea/vomiting | **Possible DKA** | **URGENT**: Ketone testing, BMP, urgent evaluation |
| **Systolic BP** | <90 mmHg | Hypotension from dehydration | **IV fluids**, assess volume status |
| **Heart Rate** | >120 bpm | Dehydration or DKA | Check BP, assess hydration, consider IV fluids |

### Symptom-Based Alerts
- **Hypoglycemia symptoms + glucose <4.0**: Immediate treatment (15-15 rule)
- **Hyperglycemia + nausea/vomiting**: **DKA evaluation** (ketones, anion gap, pH)
- **Confusion + any glucose abnormality**: **Urgent evaluation** (severe hypo or hyperglycemia)
- **Recurrent hypoglycemia** (>2 episodes/day): Medication reduction needed

---

## Care Coordination

### Telemedicine/Virtual Visits
- **Daily check-ins** during insulin titration or DKA recovery
- **Every 2 days** if stable and improving
- **Ad-hoc visits** for medication adjustments, hypoglycemia management

### Interdisciplinary Task Management
- **Phlebotomy**: Home blood draws for BMP (anion gap, ketones, renal function), HbA1c
- **IV Insulin/Hydration**: RN visits for IV insulin administration or IV fluid boluses
- **Diabetes Educator**: Virtual or home visit for insulin technique, carb counting education

---

## Treatment Protocol

### Hyperglycemia Management

#### Mild-Moderate Hyperglycemia (10-20 mmol/L)
- **Increase insulin doses** (basal or bolus):
  - Basal insulin: Increase by 10-20% (e.g., if on 20 units, increase to 22-24 units)
  - Bolus insulin: Increase meal insulin by 10-20% or add correction doses
- **Review carbohydrate intake**: Ensure consistent carb counting
- **Increase physical activity**: If safe and patient able

#### Severe Hyperglycemia (>20 mmol/L)
1. **Check for DKA**:
   - Blood ketones (β-hydroxybutyrate) or urine ketones
   - Anion gap (Na - (Cl + HCO3))
   - pH or bicarbonate
2. **If DKA present (ketones elevated + anion gap >12 + pH <7.3)**:
   - **Hospital transfer** if moderate-severe
   - **Mild DKA** (pH 7.25-7.3, bicarb 15-18): May treat at home with close monitoring
     - IV normal saline 1-2L bolus
     - IV insulin infusion (low-dose: 0.1 units/kg/hr)
     - Frequent glucose checks (Q1-2hrs)
     - Frequent BMP (Q4-6hrs initially)
3. **If no DKA (hyperglycemia alone)**:
   - Supplemental insulin (correction dose)
   - IV hydration if dehydrated
   - Increase basal insulin for next day

#### Insulin Regimens
- **Basal-bolus** (physiologic, preferred):
  - Basal: Long-acting (glargine, detemir) once daily
  - Bolus: Rapid-acting (lispro, aspart, glulisine) before meals
  - Total daily dose = 0.5-1.0 units/kg
  - 50% basal, 50% bolus (divided among meals)
- **Sliding scale** (suboptimal, reactive):
  - Only use as adjunct to basal insulin
  - Never use sliding scale alone

### Hypoglycemia Management

#### Acute Treatment (15-15 Rule)
1. **Give 15g fast-acting carbohydrate**:
   - 4 glucose tablets, OR
   - 120ml juice, OR
   - 1 tablespoon honey
2. **Recheck glucose in 15 minutes**
3. **If still <4.0 mmol/L, repeat step 1**
4. **Once >4.0 mmol/L, eat a meal or snack** (prevent recurrence)

#### Prevention
- **Identify cause**: Skipped meal, excess insulin, increased activity, alcohol
- **Adjust insulin doses**: Reduce if recurrent hypoglycemia
- **Patient education**: Always carry glucose tabs, check before driving
- **Glucagon kit**: For severe hypoglycemia (patient unconscious) - educate family

### Monitoring During Treatment
- **Glucose**: Q6hrs minimum (fasting, pre-meal, 2hrs post-meal, bedtime)
- **BMP**: Every 1-2 days (monitor K, Cr, anion gap)
- **Ketones**: Daily if DKA present, or if glucose >16.7 mmol/L
- **HbA1c**: At admission and 3 months post-discharge (assess long-term control)

---

## Complications to Monitor

### Diabetic Ketoacidosis (DKA)
- **Type 1 diabetes** most common, but can occur in Type 2
- **Triggers**: Infection, missed insulin, new diagnosis
- **Signs**: Hyperglycemia + ketones + anion gap metabolic acidosis + N/V
- **Management**: IV fluids, IV insulin, electrolyte repletion, treat precipitant

### Hyperosmolar Hyperglycemic State (HHS)
- **Type 2 diabetes**, elderly
- **Signs**: Severe hyperglycemia (>33 mmol/L), hyperosmolarity, altered mental status, NO ketones
- **Management**: Aggressive IV hydration, insulin, electrolyte repletion

### Severe Hypoglycemia
- **Glucose <2.2 mmol/L** or **unconscious**
- **Management**: Glucagon IM 1mg, call 911, D50W IV if EMS available

### Electrolyte Abnormalities
- **Hypokalemia**: Common with insulin treatment (K shifts intracellularly)
  - Replete K before starting insulin if K <3.3 mmol/L
- **Hyperkalemia**: May be present initially in DKA despite total body K depletion

---

## Comorbidity Management

See **[Comorbidity Matrix](../../shared/comorbidity-matrix.md)** for detailed guidance.

### Common Diabetes Comorbidities
- **Diabetes + HTN**: Target BP <130/80; ACE-I/ARB for renal protection
- **Diabetes + CHF**: SGLT2 inhibitors benefit both conditions
- **Diabetes + CKD**: Adjust insulin doses (renal clearance affected), avoid metformin if eGFR <30
- **Diabetes + COPD**: Steroids for COPD exacerbation worsen hyperglycemia - increase glucose monitoring to Q4hrs

---

## Transition to Post-Acute Care

### Discharge Readiness Criteria
- ✅ Glucose controlled (majority of readings in target range 4-10 mmol/L)
- ✅ No DKA/HHS (ketones negative, anion gap normalized)
- ✅ Transitioned to subcutaneous insulin regimen (off IV insulin)
- ✅ No severe hypoglycemia x24 hours
- ✅ Patient demonstrates competent glucose monitoring and insulin administration
- ✅ Has glucose meter, test strips, insulin, and supplies
- ✅ Understands hypoglycemia treatment (15-15 rule)

### Handoff to Post-Acute
See **[Transition to Post-Acute](./transition-to-postacute.md)** for full protocol.

**Key Handoff Information**:
- Final insulin regimen (basal dose, bolus doses, correction scale)
- Target glucose range (typically 4-10 mmol/L pre-meal, <12 mmol/L post-meal)
- HbA1c baseline and 90-day goal
- Diabetes educator follow-up scheduled
- Dietary plan (carb counting, meal timing)

---

## References
- Source: Carepath Diabetes Acute Care Pathway SOP
- ADA Standards of Care 2023
- DKA Diagnostic Criteria: Kitabchi AE, et al. Diabetes Care 2009
- Hypoglycemia Classification: International Hypoglycemia Study Group

**Related Skills**: After stabilization, patient transitions to `carepath-postacute` skill for 30-day glucose optimization and HbA1c improvement monitoring.
